Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Australian Prescriber is Scopus-indexed (Q2, CiteScore 4.3), WoS ESCI, DOAJ. Published by Therapeutic Guidelines Ltd.
Checked against the index lists dated .
ISSN 0312-8008Verify ISSN ↗1839-3942Verify ISSN ↗
Publisher: Therapeutic Guidelines Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 122 / 278 | 56th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1995–present, best quartile Q2, CiteScore 4.3.
Australian Prescriber is Q2 in Pharmacology (medical) (rank 122 of 278), by CiteScore 2025.
Australian Prescriber is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.3, which places it in quartile Q2 at the 56th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.687, quartile Q2, with an H-index of 50.
Australian Prescriber is published by Therapeutic Guidelines Ltd. Its print ISSN is 0312-8008 and its online ISSN is 1839-3942.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Australian Prescriber has an h-index of 62 and a 2-year mean of 2.83 citations per paper (OpenAlex). Its Scopus CiteScore is 4.3, quartile Q2. On 2-year citations it ranks #86 of 271 Scopus journals in Pharmacology (medical).
Australian Prescriber published 57 papers in 2025; its busiest recent year was 2020 with 78. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 57 research articles (2024–2026), authors are most often from Australia (88.9%), United States (5%) and United Kingdom (2.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.